BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28570009)

  • 21. Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas.
    Kuboki Y; Shimizu K; Hatori T; Yamamoto M; Shibata N; Shiratori K; Furukawa T
    Pancreas; 2015 Mar; 44(2):227-35. PubMed ID: 25423558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
    Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
    J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KRAS, GNAS, and RNF43 mutations in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis.
    Lee JH; Kim Y; Choi JW; Kim YS
    Springerplus; 2016; 5(1):1172. PubMed ID: 27512631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucinous cystic neoplasms of the pancreas with ovarian stroma.
    Gil E; Choi SH; Choi DW; Heo JS; Kim MJ
    ANZ J Surg; 2013 Dec; 83(12):985-90. PubMed ID: 23072713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients with a resected pancreatic mucinous cystic neoplasm have a better prognosis than patients with an intraductal papillary mucinous neoplasm: A large single institution series.
    Griffin JF; Page AJ; Samaha GJ; Christopher A; Bhaijee F; Pezhouh MK; Peters NA; Hruban RH; He J; Makary MA; Lennon AM; Cameron JL; Wolfgang CL; Weiss MJ
    Pancreatology; 2017; 17(3):490-496. PubMed ID: 28416122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.
    Tamura K; Ohtsuka T; Ideno N; Aso T; Shindo K; Aishima S; Ohuchida K; Takahata S; Ushijima Y; Ito T; Oda Y; Mizumoto K; Tanaka M
    Ann Surg; 2014 Feb; 259(2):360-8. PubMed ID: 23989056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucinous cystic neoplasm of the pancreas: is surgical resection recommended for all surgically fit patients?
    Park JW; Jang JY; Kang MJ; Kwon W; Chang YR; Kim SW
    Pancreatology; 2014; 14(2):131-6. PubMed ID: 24650968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical analysis of steroidogenic enzymes in ovarian-type stroma of pancreatic mucinous cystic neoplasms: Comparative study of subepithelial stromal cells in intraductal papillary mucinous neoplasms of the pancreas.
    Ishida K; Sasano H; Moriya T; Takahashi Y; Sugimoto R; Mue Y; Murakami K; Fujishima F; Nakamura Y; Morikawa T; Motoi F; Suzuki T; Unno M; Sugai T
    Pathol Int; 2016 May; 66(5):281-7. PubMed ID: 27060902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine.
    Kumagai R; Kohashi K; Takahashi S; Yamamoto H; Hirahashi M; Taguchi K; Nishiyama K; Oda Y
    World J Gastroenterol; 2015 Mar; 21(9):2700-10. PubMed ID: 25759539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucinous cystic neoplasms of the pancreas: update on the surgical pathology and molecular genetics.
    Fukushima N; Zamboni G
    Semin Diagn Pathol; 2014 Nov; 31(6):467-474. PubMed ID: 25441310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of malignancy in resected pancreatic mucinous cystic neoplasms.
    Keane MG; Shamali A; Nilsson LN; Antila A; Millastre Bocos J; Marijinissen Van Zanten M; Verdejo Gil C; Maisonneuve P; Vaalavuo Y; Hoskins T; Robinson S; Ceyhan GO; Abu Hilal M; Pereira SP; Laukkarinen J; Del Chiaro M
    Br J Surg; 2018 Mar; 105(4):439-446. PubMed ID: 29488646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GNAS is frequently mutated in both low-grade and high-grade disseminated appendiceal mucinous neoplasms but does not affect survival.
    Singhi AD; Davison JM; Choudry HA; Pingpank JF; Ahrendt SA; Holtzman MP; Zureikat AH; Zeh HJ; Ramalingam L; Mantha G; Nikiforova M; Bartlett DL; Pai RK
    Hum Pathol; 2014 Aug; 45(8):1737-43. PubMed ID: 24925222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratumor Heterogeneity of KRAS Mutation Status in Pancreatic Ductal Adenocarcinoma Is Associated With Smaller Lesions.
    Nagawkar SS; Abu-Funni S; Simon E; Bick T; Prinz E; Sabo E; Ben-Izhak O; Hershkovitz D
    Pancreas; 2016 Jul; 45(6):876-81. PubMed ID: 26646269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.
    Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB
    Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commercial molecular panels are of limited utility in the classification of pancreatic cystic lesions.
    Panarelli NC; Sela R; Schreiner AM; Crapanzano JP; Klimstra DS; Schnoll-Sussman F; Pochapin MB; Yantiss RK
    Am J Surg Pathol; 2012 Oct; 36(10):1434-43. PubMed ID: 22982886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignancy risk factors and prognostic variables of pancreatic mucinous cystic neoplasms in Chinese patients.
    Xia Q; Li F; Min R; Sun S; Han YX; Feng ZZ; Li N
    World J Gastroenterol; 2023 May; 29(20):3119-3132. PubMed ID: 37346158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KRAS, BRAF, and PIK3CA mutations, and patient prognosis in 126 pancreatic cancers: pyrosequencing technology and literature review.
    Zhou L; Baba Y; Kitano Y; Miyake K; Zhang X; Yamamura K; Kosumi K; Kaida T; Arima K; Taki K; Higashi T; Imai K; Hashimoto D; Yamashita Y; Chikamoto A; Beppu T; Tan X; Baba H
    Med Oncol; 2016 Apr; 33(4):32. PubMed ID: 26927447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of mucinous cystic neoplasms of the pancreas defined by ovarian-type stroma: clinicopathological features of 344 patients.
    Goh BK; Tan YM; Chung YF; Chow PK; Cheow PC; Wong WK; Ooi LL
    World J Surg; 2006 Dec; 30(12):2236-45. PubMed ID: 17103100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Profiling Reveals a Clonal Relationship Between Ovarian Mucinous Tumors and Corresponding Mural Carcinomatous Nodules.
    Mesbah Ardakani N; Giardina T; Amanuel B; Stewart CJ
    Am J Surg Pathol; 2017 Sep; 41(9):1261-1266. PubMed ID: 28498287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinctive immunohistochemical profile of mucinous cystic neoplasms of pancreas, ovary and lung.
    Silverman JF; Zhu B; Liu Y; Lin X
    Histol Histopathol; 2009 Jan; 24(1):77-82. PubMed ID: 19012247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.